Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 5/20 | 0.75 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | JAK2 | O60674 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7531705 | 0.84 | PKM (0.75) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL14314685 | 0.84 | PKM (0.65) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL12726891 | 0.84 | PKM (0.69) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL14314684 | 0.83 | PKM (0.63) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL2888089 | 0.83 | PKM (0.63) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL9597683 | 0.82 | RAB9A (0.73) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL9597306 | 0.82 | PKM (0.71) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL27748352 | 0.82 | PKM (0.71) | PKMRAB9ANPC1LMNASMN1; SMN2 | |
| SCHEMBL19002724 | 0.80 | MEN1 (0.68) | PKMRAB9ANPC1LMNAALDH1A1 | |
| SCHEMBL5415687 | 0.80 | PKM (0.85) | PKMRAB9ANPC1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174867-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-05-30 | — | — | US | claimed |
| EP-4301817-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-Desoto International, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| CN-117321150-A | Corrosion inhibiting coating composition | PRC-迪索托国际公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2022187845-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| US-12577412-B2 | Corrosion inhibiting coating compositions | PRC-DESOTO INTERNATIONAL, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| WO-2025151695-A1 | COATING COMPOSITIONS COMPRISING MAGNESIUM OXIDE AND A LITHIUM COMPOUND | PRC-DESOTO INTERNATIONAL, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-20240174867-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| EP-4301817-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-Desoto International, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| CN-117321150-A | Corrosion inhibiting coating composition | PRC-迪索托国际公司 | 2023-12-29 | — | — | CN | disclosed |
| WO-2022187845-A1 | CORROSION INHIBITING COATING COMPOSITIONS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2022-09-09 | — | — | WO | disclosed |
| US-8993563-B2 | Phosphoinositide 3-kinase inhibitor compounds and methods of use | GENENTECH, INC. (US) | 2015-03-31 | — | — | US | disclosed |
| US-20130129820-A1 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129820-A1 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR COMPOUNDS AND METHODS OF USE | PIK3CA, AKT3, PI4KA | PKM 361/4885RAB9A 986/4885NPC1 991/4885 |
| US-12577412-B2 | Corrosion inhibiting coating compositions | MGMT, MBD2, MECP2 | PKM 2270/4885RAB9A 2485/4885NPC1 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.